Introduction:Basic information about CAS 65836-72-8|2-Chloro-N-(3,4-dimethoxybenzyl)acetamide, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 2-Chloro-N-(3,4-dimethoxybenzyl)acetamide |
|---|
| CAS Number | 65836-72-8 | Molecular Weight | 243.68700 |
|---|
| Density | 1.194g/cm3 | Boiling Point | 425.7ºC at 760 mmHg |
|---|
| Molecular Formula | C11H14ClNO3 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 211.3ºC |
|---|
Names
| Name | 2-chloro-N-[(3,4-dimethoxyphenyl)methyl]acetamide |
|---|
| Synonym | More Synonyms |
|---|
BiologicalActivity
| Description | DKM 2-93 is a relatively selective inhibitor of UBA5 with an IC50 of 430 μM. |
|---|
| Related Catalog | Signaling Pathways >>Metabolic Enzyme/Protease >>E1/E2/E3 EnzymeResearch Areas >>Cancer |
|---|
| Target | IC50: 430 μM (UBA5), 90 μM (PaCa2 cells), 30 μM (Panc1 cells)[1] |
|---|
| In Vitro | Ubiquitin-like modifier activating enzyme 5 (UBA5) is a novel pancreatic cancer therapeutic target. DKM 2-93 impairs pancreatic cancer cell survival through covalently modifying the catalytic cysteine of UBA5, thereby inhibiting its activity as a protein that activates the ubiquitin-like protein UFM1 to UFMylate proteins. DKM 2-93 inhibits PaCa2 and Panc1 cells survival with IC50s of 90 and 30 μM, respectively[1]. |
|---|
| In Vivo | DKM 2-93 daily treatment significantly impairs tumor growth of PaCa2 cells in vivo in tumor xenograft studies in immune-deficient mice without causing any weight loss or overt toxicity[1]. |
|---|
| Cell Assay | PaCa2 and Panc1 cells are treated with 0-1000 μM DKM 2-93 for 48 hours. Cell viability is assessed by Hoescht stain[1]. |
|---|
| Animal Admin | Mice: Mice are subcutaneously injected with PaCa2 cells to initiate the tumor xenograft study and treatments of mice are initiated with vehicle or DKM 2-93 (50 mg/kg ip, once per day) three days after injection of cancer cells[1]. |
|---|
| References | [1]. Roberts AM, et al. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer Target. ACS Chem Biol. 2017 Apr 21;12(4):899-904. |
|---|
Chemical & Physical Properties
| Density | 1.194g/cm3 |
|---|
| Boiling Point | 425.7ºC at 760 mmHg |
|---|
| Molecular Formula | C11H14ClNO3 |
|---|
| Molecular Weight | 243.68700 |
|---|
| Flash Point | 211.3ºC |
|---|
| Exact Mass | 243.06600 |
|---|
| PSA | 47.56000 |
|---|
| LogP | 1.94970 |
|---|
| Index of Refraction | 1.522 |
|---|
| InChIKey | CETPWRGZGWGPSV-UHFFFAOYSA-N |
|---|
| SMILES | COc1ccc(CNC(=O)CCl)cc1OC |
|---|
| Storage condition | 2-8℃ |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- AB5429210
- CHEMICAL NAME :
- Acetamide, 2-chloro-N-((3,4-dimethoxyphenyl)methyl)-
- CAS REGISTRY NUMBER :
- 65836-72-8
- BEILSTEIN REFERENCE NO. :
- 2857211
- LAST UPDATED :
- 199612
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C11-H14-Cl-N-O3
- MOLECULAR WEIGHT :
- 243.71
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD - Lethal dose
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >400 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- APFRAD Annales Pharmaceutiques Francaises. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1943- Volume(issue)/page/year: 41,457,1983
|
Safety Information
| Hazard Codes | Xi |
|---|
| HS Code | 2924299090 |
|---|
Customs
| HS Code | 2924299090 |
|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|---|
Synonyms
| Chlor-essigsaeure-veratrylamid |
| N-chloroacetyl-3,4-dimethoxybenzylamine |
| C-Chlor-N-veratryl-acetamid |
| 2-chloro-N-(3,4-dimethoxybenzyl)acetamide |
| chloro-acetic acid veratrylamide |
| N-(3.4-Dimethoxy-benzyl)-chloracetamid |
| 2-Chloro-N-((3,4-dimethoxyphenyl)methyl)acetamide |
| N-(Dimethoxy-3,4 benzyl)-chloroacetamide [French] |
| Acetamide,2-chloro-N-((3,4-dimethoxyphenyl)methyl) |
| N-Chloracetyl-(3,4-dimethoxyphenyl)methylamin |
| DKM 2-93 |